Summary
Immune health products are health products that can improve immunity and promote metabolism.
According to APO Research, The global Immune Health Product market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Immune Health Product is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Immune Health Product is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Immune Health Product is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Immune Health Product is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Immune Health Product include Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, USANA Health Sciences, Inc., PERFECT, Nestlé SA and H&H Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Immune Health Product, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Immune Health Product, also provides the revenue of main regions and countries. Of the upcoming market potential for Immune Health Product, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immune Health Product revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Immune Health Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immune Health Product revenue, projected growth trends, production technology, application and end-user industry.
Immune Health Product segment by Company
Amway
Suntory
GNC
INFINITUS
Herbalife Nutrition
USANA Health Sciences, Inc.
PERFECT
Nestlé SA
H&H Group
China New Era Group
By-health
Black Mores
Glanbia Plc
Nature’s
Real Nutriceutical
Immune Health Product segment by Form
Capsule/Pills
Powder
Liquid
Immune Health Product segment by End Users
Children/Teenagers
Men
Adults
The Elderly
Immune Health Product segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune Health Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Immune Health Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Immune Health Product company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Health Product revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Immune Health Product Market by Form
1.2.1 Global Immune Health Product Market Size by Form, 2019 VS 2023 VS 2030
1.2.2 Capsule/Pills
1.2.3 Powder
1.2.4 Liquid
1.3 Immune Health Product Market by End Users
1.3.1 Global Immune Health Product Market Size by End Users, 2019 VS 2023 VS 2030
1.3.2 Children/Teenagers
1.3.3 Men
1.3.4 Adults
1.3.5 The Elderly
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Immune Health Product Market Dynamics
2.1 Immune Health Product Industry Trends
2.2 Immune Health Product Industry Drivers
2.3 Immune Health Product Industry Opportunities and Challenges
2.4 Immune Health Product Industry Restraints
3 Global Growth Perspective
3.1 Global Immune Health Product Market Perspective (2019-2030)
3.2 Global Immune Health Product Growth Trends by Region
3.2.1 Global Immune Health Product Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Immune Health Product Market Size by Region (2019-2024)
3.2.3 Global Immune Health Product Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Immune Health Product Revenue by Players
4.1.1 Global Immune Health Product Revenue by Players (2019-2024)
4.1.2 Global Immune Health Product Revenue Market Share by Players (2019-2024)
4.1.3 Global Immune Health Product Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Immune Health Product Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Immune Health Product Key Players Headquarters & Area Served
4.4 Global Immune Health Product Players, Product Type & Application
4.5 Global Immune Health Product Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Immune Health Product Market CR5 and HHI
4.6.2 Global Top 5 and 10 Immune Health Product Players Market Share by Revenue in 2023
4.6.3 2023 Immune Health Product Tier 1, Tier 2, and Tier 3
5 Immune Health Product Market Size by Type
5.1 Global Immune Health Product Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Immune Health Product Revenue by Type (2019-2030)
5.3 Global Immune Health Product Revenue Market Share by Type (2019-2030)
6 Immune Health Product Market Size by Application
6.1 Global Immune Health Product Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Immune Health Product Revenue by Application (2019-2030)
6.3 Global Immune Health Product Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Amway
7.1.1 Amway Comapny Information
7.1.2 Amway Business Overview
7.1.3 Amway Immune Health Product Revenue and Gross Margin (2019-2024)
7.1.4 Amway Immune Health Product Product Portfolio
7.1.5 Amway Recent Developments
7.2 Suntory
7.2.1 Suntory Comapny Information
7.2.2 Suntory Business Overview
7.2.3 Suntory Immune Health Product Revenue and Gross Margin (2019-2024)
7.2.4 Suntory Immune Health Product Product Portfolio
7.2.5 Suntory Recent Developments
7.3 GNC
7.3.1 GNC Comapny Information
7.3.2 GNC Business Overview
7.3.3 GNC Immune Health Product Revenue and Gross Margin (2019-2024)
7.3.4 GNC Immune Health Product Product Portfolio
7.3.5 GNC Recent Developments
7.4 INFINITUS
7.4.1 INFINITUS Comapny Information
7.4.2 INFINITUS Business Overview
7.4.3 INFINITUS Immune Health Product Revenue and Gross Margin (2019-2024)
7.4.4 INFINITUS Immune Health Product Product Portfolio
7.4.5 INFINITUS Recent Developments
7.5 Herbalife Nutrition
7.5.1 Herbalife Nutrition Comapny Information
7.5.2 Herbalife Nutrition Business Overview
7.5.3 Herbalife Nutrition Immune Health Product Revenue and Gross Margin (2019-2024)
7.5.4 Herbalife Nutrition Immune Health Product Product Portfolio
7.5.5 Herbalife Nutrition Recent Developments
7.6 USANA Health Sciences, Inc.
7.6.1 USANA Health Sciences, Inc. Comapny Information
7.6.2 USANA Health Sciences, Inc. Business Overview
7.6.3 USANA Health Sciences, Inc. Immune Health Product Revenue and Gross Margin (2019-2024)
7.6.4 USANA Health Sciences, Inc. Immune Health Product Product Portfolio
7.6.5 USANA Health Sciences, Inc. Recent Developments
7.7 PERFECT
7.7.1 PERFECT Comapny Information
7.7.2 PERFECT Business Overview
7.7.3 PERFECT Immune Health Product Revenue and Gross Margin (2019-2024)
7.7.4 PERFECT Immune Health Product Product Portfolio
7.7.5 PERFECT Recent Developments
7.8 Nestlé SA
7.8.1 Nestlé SA Comapny Information
7.8.2 Nestlé SA Business Overview
7.8.3 Nestlé SA Immune Health Product Revenue and Gross Margin (2019-2024)
7.8.4 Nestlé SA Immune Health Product Product Portfolio
7.8.5 Nestlé SA Recent Developments
7.9 H&H Group
7.9.1 H&H Group Comapny Information
7.9.2 H&H Group Business Overview
7.9.3 H&H Group Immune Health Product Revenue and Gross Margin (2019-2024)
7.9.4 H&H Group Immune Health Product Product Portfolio
7.9.5 H&H Group Recent Developments
7.10 China New Era Group
7.10.1 China New Era Group Comapny Information
7.10.2 China New Era Group Business Overview
7.10.3 China New Era Group Immune Health Product Revenue and Gross Margin (2019-2024)
7.10.4 China New Era Group Immune Health Product Product Portfolio
7.10.5 China New Era Group Recent Developments
7.11 By-health
7.11.1 By-health Comapny Information
7.11.2 By-health Business Overview
7.11.3 By-health Immune Health Product Revenue and Gross Margin (2019-2024)
7.11.4 By-health Immune Health Product Product Portfolio
7.11.5 By-health Recent Developments
7.12 Black Mores
7.12.1 Black Mores Comapny Information
7.12.2 Black Mores Business Overview
7.12.3 Black Mores Immune Health Product Revenue and Gross Margin (2019-2024)
7.12.4 Black Mores Immune Health Product Product Portfolio
7.12.5 Black Mores Recent Developments
7.13 Glanbia Plc
7.13.1 Glanbia Plc Comapny Information
7.13.2 Glanbia Plc Business Overview
7.13.3 Glanbia Plc Immune Health Product Revenue and Gross Margin (2019-2024)
7.13.4 Glanbia Plc Immune Health Product Product Portfolio
7.13.5 Glanbia Plc Recent Developments
7.14 Nature’s
7.14.1 Nature’s Comapny Information
7.14.2 Nature’s Business Overview
7.14.3 Nature’s Immune Health Product Revenue and Gross Margin (2019-2024)
7.14.4 Nature’s Immune Health Product Product Portfolio
7.14.5 Nature’s Recent Developments
7.15 Real Nutriceutical
7.15.1 Real Nutriceutical Comapny Information
7.15.2 Real Nutriceutical Business Overview
7.15.3 Real Nutriceutical Immune Health Product Revenue and Gross Margin (2019-2024)
7.15.4 Real Nutriceutical Immune Health Product Product Portfolio
7.15.5 Real Nutriceutical Recent Developments
8 North America
8.1 North America Immune Health Product Revenue (2019-2030)
8.2 North America Immune Health Product Revenue by Form (2019-2030)
8.2.1 North America Immune Health Product Revenue by Form (2019-2024)
8.2.2 North America Immune Health Product Revenue by Form (2025-2030)
8.3 North America Immune Health Product Revenue Share by Form (2019-2030)
8.4 North America Immune Health Product Revenue by End Users (2019-2030)
8.4.1 North America Immune Health Product Revenue by End Users (2019-2024)
8.4.2 North America Immune Health Product Revenue by End Users (2025-2030)
8.5 North America Immune Health Product Revenue Share by End Users (2019-2030)
8.6 North America Immune Health Product Revenue by Country
8.6.1 North America Immune Health Product Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Immune Health Product Revenue by Country (2019-2024)
8.6.3 North America Immune Health Product Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Immune Health Product Revenue (2019-2030)
9.2 Europe Immune Health Product Revenue by Form (2019-2030)
9.2.1 Europe Immune Health Product Revenue by Form (2019-2024)
9.2.2 Europe Immune Health Product Revenue by Form (2025-2030)
9.3 Europe Immune Health Product Revenue Share by Form (2019-2030)
9.4 Europe Immune Health Product Revenue by End Users (2019-2030)
9.4.1 Europe Immune Health Product Revenue by End Users (2019-2024)
9.4.2 Europe Immune Health Product Revenue by End Users (2025-2030)
9.5 Europe Immune Health Product Revenue Share by End Users (2019-2030)
9.6 Europe Immune Health Product Revenue by Country
9.6.1 Europe Immune Health Product Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Immune Health Product Revenue by Country (2019-2024)
9.6.3 Europe Immune Health Product Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Immune Health Product Revenue (2019-2030)
10.2 China Immune Health Product Revenue by Form (2019-2030)
10.2.1 China Immune Health Product Revenue by Form (2019-2024)
10.2.2 China Immune Health Product Revenue by Form (2025-2030)
10.3 China Immune Health Product Revenue Share by Form (2019-2030)
10.4 China Immune Health Product Revenue by End Users (2019-2030)
10.4.1 China Immune Health Product Revenue by End Users (2019-2024)
10.4.2 China Immune Health Product Revenue by End Users (2025-2030)
10.5 China Immune Health Product Revenue Share by End Users (2019-2030)
11 Asia (Excluding China)
11.1 Asia Immune Health Product Revenue (2019-2030)
11.2 Asia Immune Health Product Revenue by Form (2019-2030)
11.2.1 Asia Immune Health Product Revenue by Form (2019-2024)
11.2.2 Asia Immune Health Product Revenue by Form (2025-2030)
11.3 Asia Immune Health Product Revenue Share by Form (2019-2030)
11.4 Asia Immune Health Product Revenue by End Users (2019-2030)
11.4.1 Asia Immune Health Product Revenue by End Users (2019-2024)
11.4.2 Asia Immune Health Product Revenue by End Users (2025-2030)
11.5 Asia Immune Health Product Revenue Share by End Users (2019-2030)
11.6 Asia Immune Health Product Revenue by Country
11.6.1 Asia Immune Health Product Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Immune Health Product Revenue by Country (2019-2024)
11.6.3 Asia Immune Health Product Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Immune Health Product Revenue (2019-2030)
12.2 MEALA Immune Health Product Revenue by Form (2019-2030)
12.2.1 MEALA Immune Health Product Revenue by Form (2019-2024)
12.2.2 MEALA Immune Health Product Revenue by Form (2025-2030)
12.3 MEALA Immune Health Product Revenue Share by Form (2019-2030)
12.4 MEALA Immune Health Product Revenue by End Users (2019-2030)
12.4.1 MEALA Immune Health Product Revenue by End Users (2019-2024)
12.4.2 MEALA Immune Health Product Revenue by End Users (2025-2030)
12.5 MEALA Immune Health Product Revenue Share by End Users (2019-2030)
12.6 MEALA Immune Health Product Revenue by Country
12.6.1 MEALA Immune Health Product Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Immune Health Product Revenue by Country (2019-2024)
12.6.3 MEALA Immune Health Product Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Immune Health Product Market Size Growth Rate by Form (US$ Million), 2019 VS 2023 VS 2030
Table 1. Capsule/Pills Major Manufacturers
Table 2. Powder Major Manufacturers
Table 3. Liquid Major Manufacturers
Table 4. Global Immune Health Product Market Size Growth Rate by End Users (US$ Million), 2019 VS 2023 VS 2030
Table 5. Children/Teenagers Major Manufacturers
Table 6. Men Major Manufacturers
Table 7. Adults Major Manufacturers
Table 8. The Elderly Major Manufacturers
Table 9. Immune Health Product Industry Trends
Table 10. Immune Health Product Industry Drivers
Table 11. Immune Health Product Industry Opportunities and Challenges
Table 12. Immune Health Product Industry Restraints
Table 13. Global Immune Health Product Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Immune Health Product Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Immune Health Product Market Share by Region (2019-2024)
Table 16. Global Immune Health Product Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Immune Health Product Market Share by Region (2025-2030)
Table 18. Global Immune Health Product Revenue by Players (US$ Million) & (2019-2024)
Table 19. Global Immune Health Product Revenue Market Share by Players (2019-2024)
Table 20. Global Immune Health Product Key Players Ranking, 2022 VS 2023 VS 2024
Table 21. Global Immune Health Product Key Players Headquarters & Area Served
Table 22. Global Immune Health Product Players, Product Type & Application
Table 23. Global Immune Health Product Players Commercialization Time
Table 24. Global Players Market Concentration Ratio (CR5 and HHI)
Table 25. Global Immune Health Product by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Immune Health Product Revenue by Form 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Immune Health Product Revenue by Form (2019-2024) & (US$ Million)
Table 28. Global Immune Health Product Revenue by Form (2025-2030) & (US$ Million)
Table 29. Global Immune Health Product Revenue Market Share by Form (2019-2024) & (US$ Million)
Table 30. Global Immune Health Product Revenue Market Share by Form (2025-2030) & (US$ Million)
Table 31. Global Immune Health Product Revenue by End Users 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Immune Health Product Revenue by End Users (2019-2024) & (US$ Million)
Table 33. Global Immune Health Product Revenue by End Users (2025-2030) & (US$ Million)
Table 34. Global Immune Health Product Revenue Market Share by End Users (2019-2024) & (US$ Million)
Table 35. Global Immune Health Product Revenue Market Share by End Users (2025-2030) & (US$ Million)
Table 36. Amway Company Information
Table 37. Amway Business Overview
Table 38. Amway Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. Amway Immune Health Product Product Portfolio
Table 40. Amway Recent Development
Table 41. Suntory Company Information
Table 42. Suntory Business Overview
Table 43. Suntory Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. Suntory Immune Health Product Product Portfolio
Table 45. Suntory Recent Development
Table 46. GNC Company Information
Table 47. GNC Business Overview
Table 48. GNC Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. GNC Immune Health Product Product Portfolio
Table 50. GNC Recent Development
Table 51. INFINITUS Company Information
Table 52. INFINITUS Business Overview
Table 53. INFINITUS Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. INFINITUS Immune Health Product Product Portfolio
Table 55. INFINITUS Recent Development
Table 56. Herbalife Nutrition Company Information
Table 57. Herbalife Nutrition Business Overview
Table 58. Herbalife Nutrition Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. Herbalife Nutrition Immune Health Product Product Portfolio
Table 60. Herbalife Nutrition Recent Development
Table 61. USANA Health Sciences, Inc. Company Information
Table 62. USANA Health Sciences, Inc. Business Overview
Table 63. USANA Health Sciences, Inc. Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. USANA Health Sciences, Inc. Immune Health Product Product Portfolio
Table 65. USANA Health Sciences, Inc. Recent Development
Table 66. PERFECT Company Information
Table 67. PERFECT Business Overview
Table 68. PERFECT Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. PERFECT Immune Health Product Product Portfolio
Table 70. PERFECT Recent Development
Table 71. Nestlé SA Company Information
Table 72. Nestlé SA Business Overview
Table 73. Nestlé SA Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. Nestlé SA Immune Health Product Product Portfolio
Table 75. Nestlé SA Recent Development
Table 76. H&H Group Company Information
Table 77. H&H Group Business Overview
Table 78. H&H Group Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. H&H Group Immune Health Product Product Portfolio
Table 80. H&H Group Recent Development
Table 81. China New Era Group Company Information
Table 82. China New Era Group Business Overview
Table 83. China New Era Group Immune Health Product Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 84. China New Era Group Immune Health Product Product Portfolio
Table 85. China New Era Group Recent Development
Table 86. By-health Company Information
Table 87. By-health Business Overview
Table 88. By-health Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. By-health Immune Health Product Product Portfolio
Table 90. By-health Recent Development
Table 91. Black Mores Company Information
Table 92. Black Mores Business Overview
Table 93. Black Mores Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Black Mores Immune Health Product Product Portfolio
Table 95. Black Mores Recent Development
Table 96. Glanbia Plc Company Information
Table 97. Glanbia Plc Business Overview
Table 98. Glanbia Plc Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Glanbia Plc Immune Health Product Product Portfolio
Table 100. Glanbia Plc Recent Development
Table 101. Nature’s Company Information
Table 102. Nature’s Business Overview
Table 103. Nature’s Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Nature’s Immune Health Product Product Portfolio
Table 105. Nature’s Recent Development
Table 106. Real Nutriceutical Company Information
Table 107. Real Nutriceutical Business Overview
Table 108. Real Nutriceutical Immune Health Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Real Nutriceutical Immune Health Product Product Portfolio
Table 110. Real Nutriceutical Recent Development
Table 111. North America Immune Health Product Revenue by Form (2019-2024) & (US$ Million)
Table 112. North America Immune Health Product Revenue by End Users (2019-2024) & (US$ Million)
Table 113. North America Immune Health Product Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. North America Immune Health Product Revenue by Country (2019-2024) & (US$ Million)
Table 115. North America Immune Health Product Revenue by Country (2025-2030) & (US$ Million)
Table 116. Europe Immune Health Product Revenue by Form (2019-2024) & (US$ Million)
Table 117. Europe Immune Health Product Revenue by End Users (2019-2024) & (US$ Million)
Table 118. Europe Immune Health Product Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 119. Europe Immune Health Product Revenue by Country (2019-2024) & (US$ Million)
Table 120. Europe Immune Health Product Revenue by Country (2025-2030) & (US$ Million)
Table 121. China Immune Health Product Revenue by Form (2019-2024) & (US$ Million)
Table 122. China Immune Health Product Revenue by End Users (2019-2024) & (US$ Million)
Table 123. Asia Immune Health Product Revenue by Form (2019-2024) & (US$ Million)
Table 124. Asia Immune Health Product Revenue by End Users (2019-2024) & (US$ Million)
Table 125. Asia Immune Health Product Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 126. Asia Immune Health Product Revenue by Country (2019-2024) & (US$ Million)
Table 127. Asia Immune Health Product Revenue by Country (2025-2030) & (US$ Million)
Table 128. MEALA Immune Health Product Revenue by Form (2019-2024) & (US$ Million)
Table 129. MEALA Immune Health Product Revenue by End Users (2019-2024) & (US$ Million)
Table 130. MEALA Immune Health Product Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 131. MEALA Immune Health Product Revenue by Country (2019-2024) & (US$ Million)
Table 132. MEALA Immune Health Product Revenue by Country (2025-2030) & (US$ Million)
Table 133. Research Programs/Design for This Report
Table 134. Authors List of This Report
Table 135. Secondary Sources
Table 136. Primary Sources
List of Figures
Figure 1. Immune Health Product Product Picture
Figure 2. Global Immune Health Product Market Size Growth Rate by Form (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Immune Health Product Market Size Share 2019 VS 2023 VS 2030
Figure 4. Capsule/Pills Picture
Figure 5. Powder Picture
Figure 6. Liquid Picture
Figure 7. Global Immune Health Product Market Size Growth Rate by End Users (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Immune Health Product Market Size Share 2019 VS 2023 VS 2030
Figure 9. Children/Teenagers Picture
Figure 10. Men Picture
Figure 11. Adults Picture
Figure 12. The Elderly Picture
Figure 13. Global Immune Health Product Market Size (US$ Million) & (2019-2030)
Figure 14. Global Immune Health Product Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Immune Health Product Market Share by Region: 2019 VS 2023 VS 2030
Figure 16. Global Immune Health Product Players Revenue Share Top 10 and Top 5 in 2023
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global Immune Health Product Revenue by Form (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Immune Health Product Revenue Market Share 2019 VS 2023 VS 2030
Figure 20. Global Immune Health Product Revenue Market Share by Form (2019-2030)
Figure 21. Global Immune Health Product Revenue by End Users (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Immune Health Product Revenue Market Share by End Users (2019 VS 2023 VS 2030)
Figure 23. Global Immune Health Product Revenue Market Share by End Users (2019-2030)
Figure 24. North America Immune Health Product Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Immune Health Product Revenue by Type (2025-2030) & (US$ Million)
Figure 26. North America Immune Health Product Revenue Share by Type (2019-2030)
Figure 27. North America Immune Health Product Revenue by Application (2025-2030) & (US$ Million)
Figure 28. North America Immune Health Product Revenue Share by Application (2019-2030)
Figure 29. North America Immune Health Product Revenue Share by Country (2019-2030)
Figure 30. United States Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Canada Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Europe Immune Health Product Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Immune Health Product Revenue by Type (2025-2030) & (US$ Million)
Figure 34. Europe Immune Health Product Revenue Share by Type (2019-2030)
Figure 35. Europe Immune Health Product Revenue by Application (2025-2030) & (US$ Million)
Figure 36. Europe Immune Health Product Revenue Share by Application (2019-2030)
Figure 37. Europe Immune Health Product Revenue Share by Country (2019-2030)
Figure 38. Germany Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. France Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. U.K. Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Italy Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Russia Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Nordic Countries Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. China Immune Health Product Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Immune Health Product Revenue by Type (2025-2030) & (US$ Million)
Figure 46. China Immune Health Product Revenue Share by Type (2019-2030)
Figure 47. China Immune Health Product Revenue by Application (2025-2030) & (US$ Million)
Figure 48. China Immune Health Product Revenue Share by Application (2019-2030)
Figure 49. Asia Immune Health Product Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 50. Asia Immune Health Product Revenue by Type (2025-2030) & (US$ Million)
Figure 51. Asia Immune Health Product Revenue Share by Type (2019-2030)
Figure 52. Asia Immune Health Product Revenue by Application (2025-2030) & (US$ Million)
Figure 53. Asia Immune Health Product Revenue Share by Application (2019-2030)
Figure 54. Asia Immune Health Product Revenue Share by Country (2019-2030)
Figure 55. Japan Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. South Korea Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. India Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Australia Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. China Taiwan Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Southeast Asia Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. MEALA Immune Health Product Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 62. MEALA Immune Health Product Revenue by Type (2025-2030) & (US$ Million)
Figure 63. MEALA Immune Health Product Revenue Share by Type (2019-2030)
Figure 64. MEALA Immune Health Product Revenue by Application (2025-2030) & (US$ Million)
Figure 65. MEALA Immune Health Product Revenue Share by Application (2019-2030)
Figure 66. MEALA Immune Health Product Revenue Share by Country (2019-2030)
Figure 67. Mexico Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. South Korea Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Brazil Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Israel Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Argentina Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Colombia Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Turkey Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Saudi Arabia Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. UAE Immune Health Product Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
